Table 3.
Disease-free survival | Overall survival | ||||||
HR | 95% Cl | P-value | HR | 95% Cl | P-value | ||
Maspin | |||||||
Positive vs. negative | 2.733 | 0.609–12.262 | 0.189 | 3.505 | 0.684–17.953 | 0.132 | |
FIGO stage | |||||||
I,II vs. III, IV | 0.070 | 0.015–0.324 | 0.001* | 0.101 | 0.024–0.419 | 0.002* | |
Tumor size | |||||||
< 40mm vs. ≥ 40mm | 0.958 | 0.345–2.665 | 0.935 | 2.350 | 0.693–7.968 | 0.170 | |
Lymph node metastasis | |||||||
Positive vs. negative | 0.823 | 0.215–3.142 | 0.775 | 2.117 | 0.573–7.823 | 0.261 |
*P < 0.05.
CI, confidence interval; FIGO, The International Federation of Gynecology and Obstetrics; HR, hazard ratio.